ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Phenylephrine 5% SDU Faure:Novartis Pharma Schweiz AG
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
S01FB02 - EphedrineATC-DDD Version 2016. Source: WHO
S - Sensory Organs

A formulation approved both for use in the eye/ear is classified in S03. Formulations approved for eye, ear and nose are also classified in S03. Formulations only licensed for use in the eye or the ear are classified in S01 and S02, respectively.

S01 - Ophthalmologicals

Most of the drugs in this group are topical preparations. Systemic preparations with clear ophthalmological indications are also classified in this group.
Small amounts of antiseptics in eye preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

DDDs have been assigned for antiglaucoma preparations only.

S01F - Mydriatics and Cycloplegics
 
S01FB - Sympathomimetics Excl. Antiglaucoma Preparations

Phenylephrine in high strength is classified in this group, see also S01GA.
Sympathomimetics used in glaucoma therapy, see S01EA.

S01FB02 - Ephedrine
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home